Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension
β Scribed by Soni Pullamsetti; Ladislau Kiss; Ardeschir Hossein Ghofrani; Robert Voswinckel; Peter Haredza; Walter Klepetko; Clemens Aigner; Ludger Fink; Jai Prakash Muyal; Norbert Weissmann; Friedrich Grimminger; Werner Seeger; Ralph Theo Schermuly
- Publisher
- BioMed Central
- Year
- 2005
- Tongue
- English
- Weight
- 187 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1471-2210
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background: Nitric oxide (no) synthesis is inhibited by the adma that accumulates in the plasma of patients with renal failure; however, the concentration of sdma also is enhanced. therefore, it has been hypothesized that adma and sdma may contribute to hypertension in these patients. ## Method
Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase (NOS), may be related to reduced biosynthesis of nitric oxide in diseases associated with accelerated atherosclerosis. The closely related compound symmetric dimethylarginine (SDMA) does not inhibit NOS, but may com
## Abstract ## Objective To compare microvascular and macrovascular functions in a cohort of patients with primary and secondary Raynaud's phenomenon (RP) who were matched for demographic, risk factor, and severity profiles. ## Methods Forty patients with primary or secondary RP matched for vasc
## Background: Intestinal microvessels of patients with inflammatory bowel disease (ibd) show microvascular endothelial dysfunction. it may contribute to reduced perfusion, poor ulcer healing, and sustained chronic inflammation. the aim of the study was to assess endothelial dysfunction and oxidati